what to eat when on tirzepatide Starting or already Mounjaro? you still matters 🍽️ If you're using Mounjaro (tirzepatide) for weight management, you may notice your appetite is much lower and you feel full very Tirzepatide & Diet: What to

Long-Term Results : The full benefits of weight loss medication typically become most evident after several months of consistent use

Every Semaglutide pen comes with an expiration date clearly marked on the packaging

For researchers tracking these developments, the retatrutide availability timeline is worth monitoring closely

Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono

The approval of semaglutide signifies its utility in addressing the complications associated with diabetes and obesity, such as: Heart disease Stroke Kidney problems Nerve damage Eye problems This medication plays a crucial role in enhancing overall health and decreasing the risk of heart attacks, strokes, and other diabetes-related complications